By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fovea Pharmaceuticals 

Paris      France
Phone: n/a Fax:


Start Up

Company News
Ariana Pharma Collaborates With Fovea Pharmaceuticals On Phase II Clinical Data Analysis 2/4/2010 3:16:49 PM
Sanofi-Aventis (France) (SASY.PA) to Buy Dyax Corp. (DYAX)'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals 10/13/2009 6:50:52 AM
CombinatoRx, Incorporated (CRXX)-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis K.K. Through Proposed Acquisition of Fovea Pharmaceuticals 10/5/2009 9:58:57 AM
Fovea Pharmaceuticals to be Acquired by Sanofi-Aventis (France) (SASY.PA) for up to $541 Million 10/1/2009 6:49:43 AM
Fovea Pharmaceuticals Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis 5/4/2009 11:19:19 AM
CombinatoRx, Incorporated (CRXX) Collaborator Fovea Pharmaceuticals Reports Encouraging Clinical Results with CombinatoRx-Derived Combination Drug Candidate 5/4/2009 9:49:21 AM
Dyax Corp. (DYAX) (JOBS) and Fovea Pharmaceuticals Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications 2/10/2009 6:53:09 AM
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 1/7/2008 10:09:01 AM
Fovea Pharmaceuticals Completes EUR30M Series B Financing 12/12/2007 6:37:01 AM
Fovea Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With Genzyme Corporation (GENZ) 11/27/2007 7:16:11 AM